Research Article

Predictors of Increased Daytime Sleepiness in Patients with Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study

Table 2

Daytime sleepiness.

VariablesExcessive daytime sleepiness
ESS ≥ 10 ()
Normal daytime sleepiness
ESS < 10 ()
Sig.

Gender0.983
 Male628
 Female523
Age59 y (7)67 y (9)0.009
BMI27 kg/m2 (8)25 kg/m2 (5)0.912

COPD
 CAT 20 (IQR 5)12 (IQR 9)0.000
 FEV1 70% (IQR 23)75% (IQR 35)0.804
 COPD grades0.624
  Grade I3 (27.3%)17 (33.3%)
  Grade II7 (63.4%)23 (45.1%)
  Grade III1 (9.1%)7 (13.7%)
  Grade IV04 (7.8%)
 COPD risk group0.003
  Risk group A022 (43.1%)
  Risk group B10 (90.9%)18 (35.3%)
  Risk group C/D1 (9.1%)11 (21.6%)

Sleep-related breathing
 Mean AHI8 events/h (12)6 events/h (8)0.817
 Median AHI3.0 (IQR 12)4.0 (IQR 7)1.000
 AHI0.830
  Pathologic (AHI ≥ 5)5 (45.5%)25 (49.0%)
  Nonpathologic (AHI < 5)6 (54.5%)26 (51.0%)
 Median oxygen desaturations 26 (IQR 146)21 (IQR 44)0.985
 Snoring events781 (IQR 909)647 (IQR 1648)0.905

Energy expenditure
 EE at night1925 J (IQR 1431)2248 J (IQR 824)0.537
 Active EE during day1042 J (IQR 1256)1402 J (IQR 2126)0.362
 MET at night0.9 (IQR 0.2)0.9 (IQR 0.1)0.977

Sleep
 Sleep episodes8 (IQR 6)8 (IQR 7)0.644
 Total sleep time306 min (IQR 180)356 (IQR 174)0.761
 Wake time31 min (IQR 63)50 min (IQR 66)0.261
 Sleep efficiency90% (IQR 10)87% (IQR 15)0.433

Comorbidities
 Cardiovascular disease4 (36.4%)19 (37.3%)0.956
 Diabetes mellitus 3 (27.3%)4 (7.8%)0.065
 Depression2 (18.2%)5 (10.0%)0.426

Daytime sleepiness
 Mean ESS12 pts (3)5 pts (2)0.000
 Median ESS11 (IQR 6)5 (IQR 4)0.001

SNOT-20
 SNOT-20 (total)24 (IQR 25)16 (IQR 18)0.126
 ALQ subscore14 (IQR 17)7 (IQR 9)0.104

AHI: Apnea Hypopnea Index, BMI: Body Mass Index, COPD: Chronic Obstructive Pulmonary Disease, EE: energy expenditure, ESS: Epworth Sleepiness Scale, FEV1: Forced Expiratory Volume in 1 second, MET: metabolic equivalent, OSA: Obstructive Sleep Apnea, and SNOT: Sinonasal Outcome Test.